Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipoic Acid and Omega-3 Fatty Acid for Alzheimer's Disease Prevention
NCT01780974Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Apr 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-lipoic acid, omega-3 fatty acid in Alzheimer's disease (AD), sponsored by Oregon Health & Science University. Started Apr 2013; status: completed.
02
Drugs
alpha-lipoic acidomega-3 fatty acid
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01780974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01780974.